Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
F 52.87 -3.17% -1.73
AXSM closed down 3.17 percent on Thursday, April 22, 2021, on 1.64 times normal volume.
Earnings due: May 6
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical AXSM trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Slingshot Bearish Bearish Swing Setup -3.17%
Pocket Pivot Bullish Swing Setup -3.17%
New 52 Week Low Weakness -3.17%
Outside Day Range Expansion -3.17%
Oversold Stochastic Weakness -3.17%
New 52 Week Closing Low Bearish 4.42%
New 52 Week Low Weakness 4.42%
Oversold Stochastic Weakness 4.42%
Older End-of-Day Signals for AXSM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 13 hours ago
Down 3% about 15 hours ago
Down 2 % about 18 hours ago
Down 1% about 18 hours ago
2x Volume Pace about 19 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Development Pain Organ Systems Alzheimer's Disease Pain Management Chronic Pain Nervous System Disorders Central Nervous System Disorders Osteoarthritis Knee Depression Perception Treatment Of Chronic Pain Antidepressants Back Pain Chronic Condition Treatment Resistant Depression

Is AXSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 109.53
52 Week Low 50.0501
Average Volume 307,047
200-Day Moving Average 72.69
50-Day Moving Average 62.60
20-Day Moving Average 54.68
10-Day Moving Average 52.62
Average True Range 2.73
ADX 31.98
+DI 18.16
-DI 21.89
Chandelier Exit (Long, 3 ATRs ) 55.09
Chandelier Exit (Short, 3 ATRs ) 58.24
Upper Bollinger Band 59.67
Lower Bollinger Band 49.69
Percent B (%b) 0.32
BandWidth 18.25
MACD Line -2.96
MACD Signal Line -3.35
MACD Histogram 0.386
Fundamentals Value
Market Cap 1.97 Billion
Num Shares 37.3 Million
EPS -1.37
Price-to-Earnings (P/E) Ratio -38.48
Price-to-Sales 0.00
Price-to-Book 19.73
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 56.77
Resistance 3 (R3) 57.20 56.34 56.12
Resistance 2 (R2) 56.34 55.34 56.12 55.90
Resistance 1 (R1) 54.60 54.73 54.17 54.17 55.69
Pivot Point 53.74 53.74 53.52 53.52 53.74
Support 1 (S1) 52.00 52.74 51.57 51.57 50.05
Support 2 (S2) 51.14 52.13 50.92 49.84
Support 3 (S3) 49.40 51.14 49.62
Support 4 (S4) 48.97